Foghorn Therapeutics Inc.
NASDAQ:FHTX
9.67 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.888 | 5.05 | 5.769 | 17.478 | 5.599 | 5.309 | 4.184 | 6.634 | 4.49 | 3.92 | 0.713 | 0.041 | 0.279 | 0.286 | 0.251 | 0.179 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.8 | 0.835 | 0.852 | 0.864 | 2.166 | 2.059 | 0.019 | 1.102 | 25.974 | 1.925 | 1.9 | 20.494 | 18.642 | 18.726 | 16.471 | 16.113 | 13.628 | 11.503 | 13.52 | 11.292 | 0 | 0 | 0 | 0 |
| Gross Profit
| 6.088 | 4.215 | 4.917 | 16.614 | 3.433 | 3.25 | 4.165 | 5.532 | -21.484 | 1.995 | -1.187 | -20.453 | -18.363 | -18.44 | -16.22 | -15.934 | -13.628 | -11.503 | -13.52 | -11.292 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.884 | 0.835 | 0.852 | 0.951 | 0.613 | 0.612 | 0.995 | 0.834 | -4.785 | 0.509 | -1.665 | -498.854 | -65.817 | -64.476 | -64.622 | -89.017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 22.997 | 24.699 | 23.353 | 26.251 | 29.248 | 29.985 | 28.208 | 26.928 | 25.974 | 24.508 | 22.463 | 20.494 | 18.642 | 18.726 | 16.471 | 16.113 | 13.628 | 11.503 | 13.52 | 11.292 | 9.775 | 9.775 | 5.306 | 5.306 |
| General & Administrative Expenses
| 7.325 | 7.71 | 7.022 | 8.308 | 8.401 | 8.641 | 7.862 | 7.965 | 7.704 | 7.216 | 6.332 | 5.808 | 4.898 | 4.69 | 4.559 | 2.555 | 1.911 | 2.221 | 1.666 | 1.808 | 1.624 | 1.624 | 1.206 | 1.206 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.325 | 7.71 | 7.022 | 8.308 | 8.401 | 8.641 | 7.862 | 7.965 | 7.704 | 7.216 | -15.374 | 5.808 | 4.898 | 4.69 | 4.559 | 2.555 | 1.911 | 2.221 | 1.666 | 1.808 | 1.624 | 1.624 | 1.206 | 1.206 |
| Other Expenses
| 0.783 | 0.739 | 0.678 | 0.721 | 0.712 | 3.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.103 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.025 | -13.025 |
| Operating Expenses
| 30.322 | 32.409 | 30.375 | 34.559 | 37.649 | 38.626 | 36.07 | 34.893 | 33.678 | 31.724 | -73.156 | 26.302 | 23.54 | 23.416 | -18.599 | 18.668 | 15.539 | 13.724 | 15.186 | 13.1 | 11.399 | 11.399 | -6.512 | -6.512 |
| Operating Income
| -24.234 | -28.194 | -25.458 | -17.081 | -32.05 | -33.317 | -31.886 | -28.259 | -29.188 | -27.804 | -28.082 | -26.261 | -23.261 | -23.13 | -20.779 | -18.489 | -15.539 | -13.724 | -15.186 | -13.1 | -11.399 | -11.399 | -6.512 | -6.512 |
| Operating Income Ratio
| -3.518 | -5.583 | -4.413 | -0.977 | -5.724 | -6.276 | -7.621 | -4.26 | -6.501 | -7.093 | -39.386 | -640.512 | -83.373 | -80.874 | -82.785 | -103.291 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.255 | 3.178 | 3.338 | 0.721 | 0.712 | 3.389 | 3 | 2.49 | 1.875 | 0.89 | 100.158 | 0.181 | 0.15 | 0.144 | 20.71 | 0 | -0.184 | 0.001 | -0.106 | 0.008 | 0.027 | 0.027 | -0.072 | -0.072 |
| Income Before Tax
| -22.979 | -25.016 | -22.12 | -13.607 | -28.545 | -29.928 | -28.886 | -25.769 | -27.313 | -26.914 | 72.076 | -26.08 | -23.111 | -22.986 | -0.069 | -18.367 | -15.723 | -13.952 | -15.292 | -13.092 | -11.372 | -11.372 | -6.584 | -6.584 |
| Income Before Tax Ratio
| -3.336 | -4.954 | -3.834 | -0.779 | -5.098 | -5.637 | -6.904 | -3.884 | -6.083 | -6.866 | 101.088 | -636.098 | -82.835 | -80.371 | -0.274 | -102.609 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.792 | 1.986 | 0.738 | 0.942 | 0.56 | 5.247 | -2.49 | 1.875 | -0.89 | -98.676 | 0.68 | 0.645 | 0.63 | 20.509 | 18.349 | 0.014 | 0.258 | 0.072 | 0.121 | 0 | 0 | 0.021 | 0.021 |
| Net Income
| -22.979 | -25.016 | -24.106 | -14.345 | -29.487 | -30.488 | -34.133 | -23.279 | -27.313 | -26.024 | 170.751 | -26.08 | -23.111 | -22.986 | -0.069 | -18.367 | -15.723 | -13.952 | -15.292 | -13.092 | -11.372 | -11.372 | -6.584 | -6.584 |
| Net Income Ratio
| -3.336 | -4.954 | -4.179 | -0.821 | -5.266 | -5.743 | -8.158 | -3.509 | -6.083 | -6.639 | 239.483 | -636.098 | -82.835 | -80.371 | -0.274 | -102.609 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.45 | -0.59 | -0.57 | -0.34 | -0.7 | -0.73 | -0.82 | -0.56 | -0.66 | -0.63 | 4.62 | -0.71 | -0.63 | -0.62 | -0.004 | -0.51 | -0.71 | -0.63 | -0.69 | -0.59 | -2.95 | -2.95 | -0.34 | -0.34 |
| EPS Diluted
| -0.45 | -0.59 | -0.57 | -0.34 | -0.7 | -0.73 | -0.82 | -0.56 | -0.66 | -0.63 | 4.62 | -0.71 | -0.63 | -0.62 | -0.004 | -0.51 | -0.71 | -0.63 | -0.69 | -0.59 | -2.95 | -2.95 | -0.34 | -0.34 |
| EBITDA
| -23.434 | -27.359 | -24.606 | -16.217 | -31.174 | -33.317 | -37.141 | -24.926 | -26.494 | -26.103 | 70.594 | -24.72 | -21.832 | -21.728 | 1.057 | 0.237 | -15.271 | -13.44 | -14.881 | -12.809 | -11.254 | -11.254 | -6.397 | -6.397 |
| EBITDA Ratio
| -3.402 | -5.418 | -4.265 | -0.928 | -5.568 | -6.276 | -8.877 | -3.757 | -5.901 | -6.659 | 99.01 | -602.927 | -78.251 | -75.972 | 4.212 | 1.321 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |